These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2667636)

  • 41. Antenatal care of low risk obstetric patients by midwives. A randomised controlled trial.
    Giles W; Collins J; Ong F; MacDonald R
    Med J Aust; 1992 Aug; 157(3):158-61. PubMed ID: 1635487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antenatal screening for candidiasis, trichomoniasis, and gonorrhoea.
    Sparks RA; Williams GL; Boyce JM; Fitzgerald TC; Shelley G
    Br J Vener Dis; 1975 Apr; 51(2):110-5. PubMed ID: 805628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of routine haemoglobin concentration measurement before caesarean section.
    Vashisht A; Yentis S
    J Obstet Gynaecol; 2005 Feb; 25(2):131-3. PubMed ID: 15814390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium.
    Hagen MD; Garber AM; Goldie SJ; Lafata JE; Mandelblatt J; Meltzer D; Neumann P; Siegel JE; Sox HC; Tsevat J
    Med Decis Making; 2001; 21(4):307-23. PubMed ID: 11475387
    [No Abstract]   [Full Text] [Related]  

  • 45. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound exposure time in routine obstetric scanning.
    Andrews M; Webster M; Fleming JE; McNay MB
    Br J Obstet Gynaecol; 1987 Sep; 94(9):843-6. PubMed ID: 3311137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of an unsatisfactory conventional cervical cytology smear.
    Paulin H; Geldenhuys L; Naugler C
    J Obstet Gynaecol Can; 2011 Jul; 33(7):725-728. PubMed ID: 21749749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A model for quality assessment in cervical cytology used as a screening test.
    Quantin C; Dusserre L; Montaud AM; Mottot C; Feldman JP
    Qual Assur Health Care; 1992 Jun; 4(2):105-13. PubMed ID: 1511144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a new antenatal care programme on the attitudes of pregnant women and midwives towards antenatal care in Harare.
    Murira N; Munjanja SP; Zhanda I; Nystrom L; Lindmark G
    Cent Afr J Med; 1997 May; 43(5):131-5. PubMed ID: 9505452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endocervical curettage as a routine part of colposcopic examinations for abnormal cervical cytology.
    Saltzman DH; Evans MI; Warsof SL; Friedman AJ
    J Reprod Med; 1985 Nov; 30(11):871-3. PubMed ID: 4078822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antenatal care in the European Union: a survey on guidelines in all 25 member states of the Community.
    Bernloehr A; Smith P; Vydelingum V
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):22-32. PubMed ID: 16154036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of 13,797 routine cervical smears in a cytology center.
    ROGERS WS; AYRE JE; MILLAR B
    Obstet Gynecol; 1955 Nov; 6(5):487-92. PubMed ID: 13266262
    [No Abstract]   [Full Text] [Related]  

  • 53. Recommendations for routine cervical screening.
    Skegg DC; Paul C; Seddon RJ; Fitzgerald NW; Barham PM; Clements CJ
    N Z Med J; 1985 Aug; 98(784):636-9. PubMed ID: 3861975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for cervical cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2003 Nov; 103(11):101-2, 105-6, 108-9. PubMed ID: 14625432
    [No Abstract]   [Full Text] [Related]  

  • 55. 3-year interval between Pap smears adequate for women with prior negative results.
    Ohl M; Kane KY
    J Fam Pract; 2004 Mar; 53(3):172-5. PubMed ID: 15000915
    [No Abstract]   [Full Text] [Related]  

  • 56. The value of routine urine dipstick screening for protein at each prenatal visit.
    Gribble RK; Fee SC; Berg RL
    Am J Obstet Gynecol; 1995 Jul; 173(1):214-7. PubMed ID: 7631685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variation in antenatal testing over time and between clinic settings.
    Read JL; Stern RS; Thibodeau LA; Geer DE; Klapholz H
    JAMA; 1983 Mar; 249(12):1605-9. PubMed ID: 6827741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antenatal care for first time mothers: a discrete choice experiment of women's views on alternative packages of care.
    Deverill M; Lancsar E; Snaith VB; Robson SC
    Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):33-7. PubMed ID: 20456855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 'Herpes present' reported in a routine cervical cytology and how to deal with it.
    Winceslaus SJ; Levine T
    Sex Health; 2012 Nov; 9(5):493-4. PubMed ID: 23036743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variation in the definition of intrauterine growth restriction in routine antenatal care: a physician survey among gynecologists in Northwest Germany.
    Ernst SA; Brand T; Petersen K; Zeeb H
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2141-2147. PubMed ID: 28573882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.